A reality check for emerging markets

stephen-jen

The old adage that when the US sneezes the rest of the world catches a cold might be politically incorrect to say these days. But if a peak in risk asset pricing was really reached the day after the US Federal Reserve announced a third round of quantitative easing on September 13, arguably, we’re all about to get very sick.

At least this is the thinking of Stephen Jens, co-portfolio manager at SLJ Partners in London, who defiantly claims that by buying into the façade of emerging markets

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact customer services - www.fx-markets.com/static/contact-us, or view our subscription options here: https://subscriptions.fx-markets.com/subscribe

You are currently unable to copy this content. Please contact info@fx-markets.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to FX Markets? View our subscription options

You need to sign in to use this feature. If you don’t have a FX Markets account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: